Enforced HCELL expression: empowering "Step 1" to optimize the efficacy of mesenchymal stem/stromal cell therapy for stroke and other clinical conditions

Robert Sackstein

DOI: https://doi.org/10.1093/stmcls/sxae067

IF: 5.845

2024-11-09

Stem Cells

Abstract:It is now well-established that mesenchymal stem/stromal cells (MSCs) have potent tissue reparative/regenerative properties, and also exert profound anti-inflammatory and immunomodulatory effects. However, despite the abundant basic science and preclinical data highlighting the immense therapeutic potential of MSCs, we still lack an understanding of the true extent of the clinically beneficial effects of MSCs. This deficit in our clinical knowledge is due in large part to the fact that MSCs lack of effectors of cell migration, and, therefore, MSCs are incapable of parenchymal colonization at injured/inflamed tissues following the intravascular administration. In this regard, it is important to distinguish tissue "entrapment" from authentic tissue "recruitment" (also known as tissue "homing"). Entrapment, as the word implies, occurs as a consequence of these large cells (upwards of 20 μm in diameter) being distributed throughout the body in a stochastic fashion, a result of being terminally wedged within the lumen of microvessels. This microvascular lodgment occurs more frequently within sites of inflammation due to inflammation-induced vasodilation and increased blood flow to the affected tissue (the pathobiology of "rubor"). It thus may appear that MSCs possess the capacity to "seek" inflammatory sites, leading some investigators to comingle, inappropriately, the passive process of MSC tissue entrapment with the physiologically distinct, extravasation-dependent, process of tissue recruitment. In contrast to entrapment, tissue recruitment is a site-specific, active/metabolic process whereby the circulating cells expressly adhere to the target tissue endothelial cells and thereafter extravasate (this ability to cross the endothelial barrier is known as "transendothelial migration" or "transmigration"), with consequent parenchymal infiltration. The major advantage of parenchymal colonization is that MSCs release their payload of biologically active agents within the tissue itself, optimizing their capacity to sense the tissue microenvironment with the subsequent release of pertinent beneficial growth factors. In this fashion, MSCs can most effectively function in a paracrine/trophic manner, consistent with the conceptual acronym of the "MSC" being a "Medicinal Signaling Cell" as proffered by the late, pioneering, MSC investigator Dr. Arnold I. ("Arnie") Caplan. 1 Thus, the tissue-infiltrating MSC becomes a biologic factory in situ , whereas the released paracrine/trophic payload of an entrapped MSC is washed downstream by blood flow.

oncology,cell biology,hematology,biotechnology & applied microbiology,cell & tissue engineering